Russia’s Gamaleya center works on technology to quickly develop coronavirus vaccines
Headline:
Editors’ Council voices concerns over media freedom
How AP has declared US election results since 1864
Stay alert against conspiracies, warns Fakhrul
Salah Uddin made senior assistant coach of Bangladesh cricket team

Russia’s Gamaleya center works on technology to quickly develop coronavirus vaccines

The technology will be useful if the virus starts mutating rapidly
Russia’s Gamaleya center works on technology to quickly develop coronavirus vaccines
Photo: TASS


Russia’s Gamaleya National Research Center for Epidemiology and Microbiology works on the technology accelerating the creation of a novel coronavirus vaccine in case of rapid genomic alterations of the infectious agent, Alexander Gintsburg, the head of the Sputnik V vaccine center, said in a televised interview with Rossiya-1 news channel, an excerpt of which was aired on the channel on Friday.

Also read: Study: Russia's Sputnik V vaccine appears safe, effective

"The research center is working on technology which will allow developing vaccines very quickly and efficiently in case the pathogen starts mutating rapidly," he said.

Also read: Sputnik V can offer two-year protection against Covid-19: Developers

Earlier, Fedor Lisitsyn, the Gamaleya center’s lead researcher, said that none of the detected coronavirus mutations could affect the efficacy of the available vaccines.

Also read: Russia's Sputnik V developers suggest AstraZeneca to try combining vaccine

Subscribe UNB YouTube Channel
coronavirus coronavirus vaccine COVID-19 global pandemic COVID-19 pandemic Russian coronavirus vaccine Sputnik V vaccine Sputnik V Gamaleya National Research Center for Epidemiology and Microbiology Russia’s Sputnik V vaccine